# Preliminary Observations:
Clear topic/scope mismatch with ACL: the paper is an AI-for-science/materials discovery study with no core NLP component, task, dataset, or evaluation on language technologies or language agents. 

# Expected Review Outcome:

## Paper Summary
The paper proposes an “Architectural Immune System” for autonomous scientific agents that detects and corrects “synthetic fallacies” such as silent fallback to synthetic data. The framework comprises a statistical anomaly detector, a 10-tool validation ecosystem, and a hybrid optimization module that integrates predictions with constraints from public chemistry databases (ChEMBL, PubChem, CosIng). A case study on tri-functional phenylpropanoid-grafted sophorolipids (PGSLs) is used to demonstrate the approach: an initial “perfect” result produced by a Dirichlet-sampled ratio is flagged as statistically implausible and traced to a code fallback; after correction, the system converges to new ratios (36.5:38.5:25.0) and predicts SPF, CMC, and MIC values. The paper argues that mandatory self-falsification should be an architectural requirement for trustworthy autonomous science.

## Summary Of Strengths
- The central idea, making self-falsification and anomaly detection a first-class architectural component, is timely and important for autonomous research agents.
- The framework is described with reasonable detail, including a three-layer detection stack, a 10-tool validation ecosystem (Table 1), and mathematical scores (e.g., Equations 1–3, 6–11).
- The case study narratively illustrates failure detection and correction. Figure 2 explicitly walks through the pipeline from suspicious uniform ratios to code provenance tracing and re-optimization.
- The paper gives a reasonably thorough reproducibility narrative in the appendices: database queries, software stack, and environment specs. Table 2 systematically reports “autonomy metrics.”
- The figures and equations help ground the claims. For instance, Equation 11 (Mahalanobis distance) clarifies the multivariate anomaly detector at the core of the immune system, and Equation 25 formalizes the TFEI used to summarize tri-functional efficacy.

## Summary Of Weaknesses
1) Out of scope for ACL main track. The work is a materials discovery/AI-for-science paper without any language component, NLP method, or evaluation on language agents interacting with textual tools. The only tenuous overlap is a general narrative about agentic validation, not tied to language tasks, data, or evaluation.

2) Empirical claims rely solely on computational predictions without wet-lab validation. Section 5 and Appendices D–F acknowledge this, but the main narrative repeatedly frames outcomes as “authentic discovery,” which risks overclaiming. For instance, Section 5.2 reports SPF 14.3 ± 2 and MIC 285 ± 30 ppm, yet these are model extrapolations over heterogeneous database sources, not experimentally measured endpoints.

3) Limited external validation that the immune system itself improves reliability beyond the case study. The synthetic-artifact detection experiment in Appendix D is useful, but it appears self-constructed and does not benchmark against established agent-evaluation suites or comparable self-correcting systems. There is no comparison against peer agentic architectures that claim self-correction.

4) Ambiguity in target-task definitions and data provenance for supervised models. Section 5.1 reports R² = 0.94 on “existing compounds,” yet the mapping between available labels and predicted endpoints is unclear. For example, SPF is estimated via a GNN trained on UV absorption records (Eq. 17), but SPF is a formulation-level metric with protocol-dependent ground-truth, not readily supported by ChEMBL assay labels. There is no clear, held-out, like-for-like experimental SPF target to validate against.

5) Risk of dataset leakage or label mismatch is insufficiently ruled out. The paper aggregates multiple databases and converts UV/assay data into composite predictions, but the splits, scaffold-level separation, and deduplication across data sources are not fully specified in the main text. Without detailed split protocols and leakage checks in the main paper, the reported R² and AUROC may overstate generalization.

6) Over-reliance on broad tool descriptions, under-specified failure modes. While Table 1 nicely catalogs the 10 tools, only one failure mode (Dirichlet-sampled ratios) is deeply analyzed. It is unclear how the immune system behaves on silent logical errors that do not manifest as distributional anomalies, on unit scaling bugs, or on provenance errors that pass statistical screens.

7) Figures mix many modalities without rigorous quantification or clarity. In Figure 1, panel coverage is broad (A–I), but units, datasets, and validation references vary by panel. Panels (C–G) aggregate SAR/MD/meta-analytic outputs; panels (A, E) suggest TD-DFT/UV predictions. The paper would be stronger if Figure 1 explicitly linked each panel to a concrete dataset split, model, and held-out validation statistic, or showed clear uncertainties with provenance. Figure 2 is compelling process-wise, but lacks quantitative detection metrics in the main text; these only appear in Appendix D.

8) TFEI definition (Equation 25) uses fixed targets that can bias composite gains. Composite indices can obscure trade-offs unless rigorously justified. The choice of SPF_target=8 versus claim thresholds in Section 3.1 (e.g., Broad Spectrum + SPF ≥ 15 for risk-reduction) makes it easier to score high on TFEI. The paper acknowledges SPF 14.3 ± 2, which sometimes falls below 15, but then reports TFEI comparisons against “conventional” and “synthetic multi-component systems” without direct baselines or uncertainty ranges.

9) Claims of autonomy (Table 2) need clearer auditing. “Human interventions required = 0” is a strong claim. The measurement protocol for “autonomous decisions made” and “tool ecosystem validations” should be precisely defined in the main paper, with criteria for what counts as a decision or validation and how disagreements were resolved. As written, it reads like a system-internal counter rather than an externally auditable metric.

10) Missing positioning against recent agentic AI-for-science literature that specifically tackles self-correction, verification gates, and agent benchmarks. The Related Work section (Section 2) is quite high-level and omits multiple directly relevant and recent works (see below). This makes it harder to assess novelty of the architectural layer relative to the state of the art.

Explicit references to figures/tables:
- Figure 2 is a strong narrative visualization of the immune system’s role: panel A shows the suspicious ratios [39.3:34.5:26.2] and states that anomaly detection triggered the inspection; panel B diagrams the three-layer workflow; panels C–D show corrected ratios and performance comparison. This supports the central claim but would benefit from quantitative detection rates in the main figure caption (now only in Appendix D).
- Table 1 enumerates the 10 validation tools. It effectively conveys breadth but does not quantify each tool’s contribution. An ablation table in the main paper, or a per-tool detection rate, would substantiate the “ecosystem” claim.
- Table 2 lists system autonomy metrics. As noted, definitions and auditing procedures are missing from the main text, which undermines interpretability.
- Equation 11 (Mahalanobis distance) properly encodes the multivariate anomaly detection cited throughout. This is central to the synthetic-fallacy claim and should be moved from Appendix to the main method section with exact thresholds and p-value mappings.
- Equation 25 (TFEI) drives many claims in Section 5.3. The choice of targets and scaling materially affects rankings; sensitivity analyses are needed.

## Potentially Missing Related Work
1) Panapitiya et al., AutoLabs: Cognitive Multi-Agent Systems with Self-Correction for Autonomous Chemical Experimentation, 2025 — presents multi-agent self-correction for lab execution; should be discussed in Section 2 and compared methodologically to the 10-tool ecosystem, and ideally serve as an external baseline for self-correction efficacy.

2) Zeng et al., Socratic agents for autonomous scientific discovery in high-dimensional physical systems, 2026 — embeds falsification and constraint checking akin to the proposed self-falsification; discuss in Section 2 and contrast the proposed three-layer anomaly+provenance approach with Socratic interrogation loops.

3) Zhang et al., Towards Agentic Intelligence for Materials Science, 2026 — survey of agentic pipelines in materials; situate the immune system in this taxonomy in Section 2 and in Section 6.2.

4) Salas et al., AI-powered open-source infrastructure for accelerating materials discovery and advanced manufacturing, 2026 — emphasizes reproducibility and provenance; cite in Section 4.3 and Section 6.2 to connect the immune-system claims with open, auditable infrastructures.

5) Soleymanibrojeni et al., GENIUS: An Agentic AI Framework for Autonomous Design and Execution of Simulation Protocols, 2026 — autonomous repair and hallucination suppression for DFT workflows; compare in Section 4.1/4.3 and add as a reference point for error-recovery loops.

6) Ning et al., Closed-loop Auto Research for Molecular Property Prediction: Discovering and Certifying Generalizable Improvements, 2026 — separates discovery vs. certification with contamination controls; add to Section 4.5/6.1, and consider adopting a certification-style evaluation to validate immune-system gains.

7) Chen et al., ScienceAgentBench: Toward Rigorous Assessment of Language Agents for Data-Driven Scientific Discovery, 2025 — benchmark for scientific language agents; include in Section 6.1 as an external assessment suite and discuss how the immune system would affect task-level scores.

8) Wei et al., From AI for Science to Agentic Science: A Survey on Autonomous Scientific Discovery, 2025 — conceptual framework for agentic science; cite in Section 2 to frame which stages the immune system targets.

9) Gridach et al., Agentic AI for Scientific Discovery: A Survey of Progress, Challenges, and Future Directions, 2025 — survey of verification strategies and governance; cite in Section 6.4 on broader research integrity implications.

10) Zhang et al., Scaling Laws of Scientific Discovery with AI and Robot Scientists, 2025 — conceptual work; cite briefly in Section 6.4 to contextualize governance and verification gates at scale.

## Comments Suggestions And Typos
Actionable suggestions:
- Scope and venue alignment: Reframe the work for an NLP/ACL audience by (i) demonstrating the immune system on language-agent scientific tasks (e.g., table extraction, code synthesis, data cleaning) with an external benchmark such as ScienceAgentBench; (ii) presenting ablations that show how anomaly/provenance layers reduce hallucination and improve factuality in text-grounded data analysis; and/or (iii) positioning the contribution as a general method for language-enabled research agents with concrete NLP tasks in the loop.
- Strengthen external evaluation of the immune system itself: Add a main-text table comparing detection precision/recall against baselines and prior agentic systems on a shared benchmark. Move critical methods (e.g., Equation 11 thresholds, artifact seeding protocol) from Appendix D to the main paper. Include ablations quantifying the marginal contribution of each tool in Table 1.
- Clarify supervised targets and data splits: For SPF/CMC/MIC prediction, specify label sources, preprocessing, and splits in the main text, including scaffold-level splits, cross-database deduplication, and leakage checks. If SPF is proxied via UV absorption or via TD-DFT-derived features, state this clearly and validate against any available experimental SPF datasets.
- Calibrate claims and indices: Reassess TFEI (Equation 25) with sensitivity analyses for target choices; report uncertainty bounds and compare against matched baselines. In Figure 2D, include confidence intervals and statistical tests supporting “superior real-world validation” wording.
- Figures: For Figure 1, ensure each panel cites the exact dataset/model and includes units, sample sizes, and error bars where applicable. For Figure 2, add quantitative detection metrics (e.g., Appendix D precision/recall) to the caption.
- Autonomy metrics in Table 2: Define “decision,” “validation,” and “contamination events prevented,” and describe the auditing process allowing an external reproducer to verify these counts.
- Provenance and code: The paper states that all code/data are available, but no link is provided in the main text. Include a persistent, anonymized repository link with instructions and commit hashes; consider a Docker container as mentioned in Appendix E.
- Minor wording: Avoid presenting computational outputs as “authentic discovery” without experimentally verified endpoints; consider “computational hypothesis” consistently across the paper.

Questions that could raise my score if addressed convincingly in rebuttal:
- Provide an external, standardized benchmark showing that the immune system improves reliability and outcome quality for scientific language agents or code-generation tasks.
- Clarify and justify the SPF prediction target and demonstrate evaluation against experimental SPF measurements where available, or provide a transparent proxy mapping with empirical validation.
- Include a main-text ablation showing how each component in Table 1 changes precision/recall of synthetic artifact detection and downstream optimization quality.

Typos/clarifications:
- Section 4.6 header appears before Figure 1 text; consider consistent subsection placement.
- “CHARMMM” in Figure 2 caption likely “CHARMM.”
- Units and axis labels are missing or ambiguous in several subpanels of Figure 1; please standardize.

## Confidence
4: Quite sure after careful checking — I checked the main methodological and evaluation claims and their alignment with the figures/tables; the scope mismatch with ACL is unambiguous.

## Soundness
2: Poor — Several empirical claims depend on proxy labels and heterogeneous databases without sufficiently clear split/leakage controls in the main text; the evaluation of the “immune system” is primarily narrative plus an internal seeded study, with no comparison to external agent benchmarks.

## Excitement
1.5: Slightly below potentially interesting — Conceptually interesting for autonomous science, but not aligned with ACL and lacking stronger external validation.

## Overall Assessment
1: Do not resubmit — out of scope for ACL and not ready for main-track standards in terms of external evaluation and empirical grounding beyond the case study.

## Best Paper Justification
N/A.

## Limitations And Societal Impact
The paper discusses limitations in Section 6.5 and Appendices F/E: absence of wet-lab validation, inter-lab variability in databases, and need for standardized protocols. Potential positive impact includes improved research integrity through anomaly detection and provenance checks; risks include overreliance on computational predictions, premature claims leading to misinformed downstream decisions, and possible misuse if anomaly thresholds are gamed. It would help to expand on failure modes where synthetic artifacts mimic natural covariance, and to discuss governance for automated provenance tracking when sensitive or proprietary data are involved.

## Ethical concerns
None.

## Needs Ethics Review
No.

## Reproducibility
3: Reproducible with difficulty — Many details are in appendices and the paper claims full release, but the main text lacks a concrete, accessible code/data link and clearer split/leakage protocols.

## Datasets
2: Documentary — Database queries and subsets are described; without curated releases or standardized task definitions for SPF/CMC/MIC prediction, utility is limited.

## Software
2: Documentary — The paper asserts availability and describes the stack, but provides no verifiable, accessible link in the main text; usefulness depends on an actual release with instructions.